HIV Citation List: March 2 - March 15, 2012

Pubmed citations

1. HIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors Through Coordinated Structural Rearrangements. Agniswamy, J., C.H. Shen, A. Aniana, J.M. Louis, J.M. Sayer, and I.T. Weber, Biochemistry, 2012. [Epub ahead of print]; PMID[22404139].
[PubMed]. HIV_0302-031512.

2. Targeting Frameshifting in the Human Immunodeficiency Virus. Brakier-Gingras, L., J. Charbonneau, and S.E. Butcher, Expert Opinion on Therapeutic Targets, 2012. [Epub ahead of print]; PMID[22404160].
[PubMed]. HIV_0302-031512.

3. Diverse HIV Viruses are Targeted by a Conformationally Dynamic Antiviral. Caines, M.E., K. Bichel, A.J. Price, W.A. McEwan, G.J. Towers, B.J. Willett, S.M. Freund, and L.C. James, Nature Structural & Molecular Biology, 2012. [Epub ahead of print]; PMID[22407016].
[PubMed]. HIV_0302-031512.

4. Potent Antiviral HIV-1 Protease Inhibitor GRL-02031 Adapts to the Structures of Drug Resistant Mutants with Its P1'-Pyrrolidinone Ring. Chang, Y.C., X. Yu, Y. Zhang, Y. Tie, Y.F. Wang, S. Yashchuk, A.K. Ghosh, R.W. Harrison, and I.T. Weber, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22401672].

[PubMed]. HIV_0302-031512.

5. Biophysical Property and Broad anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic acid-modified Peptide Fusion Inhibitor. Chong, H., X. Yao, C. Zhang, L. Cai, S. Cui, Y. Wang, and Y. He, Plos One, 2012. 7(3): p. e32599; PMID[22403678].
[PubMed]. HIV_0302-031512.

6. Peptides from the Second Extracellular Loop of the C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1. Dogo-Isonagie, C., S. Lam, E. Gustchina, P. Acharya, Y. Yang, S. Shahzad-Ul-Hussan, G.M. Clore, P.D. Kwong, and C.A. Bewley, The Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22403408].
[PubMed]. HIV_0302-031512.

7. Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1. Dziuba, N., M. Ferguson, W.A. O'Brien, A. Sanchez, A.J. Prussia, N. McDonald, B.M. Friedrich, G. Li, M.W. Shaw, J. Sheng, T.W. Hodge, D.H. Rubin, and J.L. Murray, AIDS Research and Human Retroviruses, 2012. [Epub ahead of print]; PMID[22404213].
[PubMed]. HIV_0302-031512.

8. Substituent Effects on P2-Cyclopentyltetrahydrofuranyl urethanes: Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors. Ghosh, A.K., B.D. Chapsal, M. Steffey, J. Agniswamy, Y.F. Wang, M. Amano, I.T. Weber, and H. Mitsuya, Bioorganic & Medicinal Chemistry Letters, 2012. 22(6): p. 2308-2311; PMID[22364812].
[PubMed]. HIV_0302-031512.

9. Engagement of NKp30 on Vdelta1 T-cells Induces the Production of CCL3, CCL4 and CCL5 and Suppresses HIV-1 Replication. Hudspeth, K., M. Fogli, D.V. Correia, J. Mikulak, A. Roberto, S. Della Bella, B. Silva-Santos, and D. Mavilio, Blood, 2012. [Epub ahead of print]; PMID[22403253].
[PubMed]. HIV_0302-031512.

10. HIV Protease Inhibitors Modulate Ca(2+) Homeostasis and Potentiate Alcoholic Stress and Injury in Mice and Primary Mouse and Human Hepatocytes. Kao, E., M. Shinohara, M. Feng, M.Y. Lau, and C. Ji, Hepatology, 2012. [Epub ahead of print]; PMID[22407670].
[PubMed]. HIV_0302-031512.

11. Novel anti-HIV-1 Activity Produced by Conjugating Unsulfated Dextran with Polyl-lysine. Nakamura, K., T. Ohtsuki, H. Mori, H. Hoshino, A. Hoque, A. Oue, F. Kanou, H. Sakagami, K.I. Tanamoto, H. Ushijima, N. Kawasaki, H. Akiyama, and H. Ogawa, Antiviral Research, 2012. [Epub ahead of print]; PMID[22401805].
[PubMed]. HIV_0302-031512.

12. Quantifying the Activity of anti-HIV Treatment in Silico. Ribeiro, R.M., Nature Medicine, 2012. 18(3): p. 355-356; PMID[22395700].
[PubMed]. HIV_0302-031512.

13. Transmembrane Domain Membrane Proximal External Region but Not Surface Unit-directed Broadly Neutralizing HIV-1 Antibodies Can Restrict Dendritic Cell-mediated HIV-1 Trans-infection. Sagar, M., H. Akiyama, B. Etemad, N. Ramirez, I. Freitas, and S. Gummuluru, Journal of Infectious Diseases, 2012. [Epub ahead of print]; PMID[22396600].
[PubMed]. HIV_0302-031512.

14. New and Novel Intrinsic Host Repressive Factors against HIV-1: PAF1 Complex, HERC5 and Others. Tyagi, M. and F. Kashanchi, Retrovirology, 2012. 9(1): p. 19; PMID[22405323].
[PubMed]. HIV_0302-031512.

15. Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-based HIV-1 Protease Inhibitors. Wu, X., P. Ohrngren, A.A. Joshi, A. Trejos, M. Persson, R.K. Arvela, H. Wallberg, L. Vrang, A. Rosenquist, B.B. Samuelsson, J. Unge, and M. Larhed, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22376008].
[PubMed]. HIV_0302-031512.

16. Catechins Containing a Galloyl Moiety as Potential anti-HIV-1 Compounds. Zhao, Y., F. Jiang, P. Liu, W. Chen, and K. Yi, Drug Discovery Today, 2012. [Epub ahead of print]; PMID[22414543].
[PubMed]. HIV_0302-031512.

17. L-selectin and P-selectin Are Novel Biomarkers of Cervicovaginal Inflammation for Preclinical Mucosal Safety Assessment of anti-HIV-1 Microbicide. Zhong, M., B. He, J. Yang, R. Bao, Y. Zhang, D. Zhou, Y. Chen, L. Li, C. Han, Y. Yang, Y. Sun, Y. Cao, Y. Li, W. Shi, S. Jiang, X. Zhang, and H. Yan, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22391529].
[PubMed]. HIV_0302-031512.

18. Trimeric, Coiled-coil Extension on Peptide Fusion Inhibitor of HIV-1 Influences Selection of Resistance Pathways. Zhuang, M., W. Wang, C.J. De Feo, R. Vassell, and C.D. Weiss, Journal of Biological Chemistry, 2012. 287(11): p. 8297-8309; PMID[22235115].
[PubMed]. HIV_0302-031512.

19. Combination of Biological Screening in a Cellular Model of Viral Latency and Virtual Screening Identifies Novel Compounds that Reactivate HIV-1. Gallastegui, E., B. Marshall, D. Vidal, G. Sanchez-Duffhues, J.A. Collado, C. Alvarez-Fernandez, N. Luque, J.M. Terme, J.M. Gatell, S. Sanchez-Palomino, E. Munoz, J. Mestres, E. Verdin, and A. Jordan, Journal of Virology, 2012. 86(7): p. 3795-3808; PMID[22258251].
[PubMed]. HIV_0302-031512.

ISI Web of Knowledge citations

20. Combination of Antiretroviral Drugs as Microbicides. Balzarini, J. and D. Schols, Current HIV Research, 2012. 10(1): p. 53-60; PMID[WOS:000300409000008].
[WOS]. HIV_0302-031512.

21. Denaturation of HIV-1 Protease (PR) Monomer by Acetic acid: Mechanistic and Trajectory Insights from Molecular Dynamics Simulations and NMR. Borkar, A., M. Rout, and R. Hosur, Journal of Biomolecular Structure & Dynamics, 2012. 29(5): p. 893-903; PMID[WOS:000300074600004].
[WOS]. HIV_0302-031512.

22. Thymidine- and AZT-linked 5-(1,3-Dioxoalkyl)tetrazoles and 4-(1,3-Dioxoalkyl)-1,2,3-triazoles. Bosch, L., O. Delelis, F. Subra, E. Deprez, M. Witvrow, and J. Vilarrasa, Tetrahedron Letters, 2012. 53(5): p. 514-518; PMID[WOS:000300029000011].
[WOS]. HIV_0302-031512.

23. Synthesis of 1,5-Benzothiazepine Derivatives Bearing 2-Phenoxy-quinoline Moiety via 1,3-Diplolar Cycloaddition Reaction. Dong, Z.Q., F.M. Liu, F. Xu, and Z.L. Yuan, Molecular Diversity, 2011. 15(4): p. 963-970; PMID[WOS:000300364700014].
[WOS]. HIV_0302-031512.

24. Phenols with anti-HIV Activity from Daphne acutiloba. Huang, S.Z., X. Zhang, X. Li, H. Jiang, Q. Ma, P. Wang, Y. Liu, J. Hu, Y. Zheng, J. Zhou, and Y. Zhao, Planta Medica, 2012. 78(2): p. 182-185; PMID[WOS:000299909300014].
[WOS]. HIV_0302-031512.

25. Evaluation of Competing Process Concepts for the Production of Pure Enantiomers. Kaspereit, M., S. Swernath, and A. Kienle, Organic Process Research & Development, 2012. 16(2): p. 353-363; PMID[WOS:000300339700024].
[WOS]. HIV_0302-031512.

26. A QSAR Study on a Series of N-Methyl pyrimidones Acting as HIV Integrase Inhibitors. Kaushik, S., S. Gupta, P. Sharma, and Z. Anwer, Indian Journal of Biochemistry & Biophysics, 2011. 48(6): p. 427-434; PMID[WOS:000299859600009].
[WOS]. HIV_0302-031512.

27. Recent Advances in the Development of Small-molecule Compounds Targeting HIV-1 gp41 as Membrane Fusion Inhibitors. Kawashita, N., Y.S. Tian, U.C. de Silva, K. Okamoto, and T. Takagi, Mini-Reviews in Organic Chemistry, 2012. 9(1): p. 20-26; PMID[WOS:000300407400005].
[WOS]. HIV_0302-031512.

28. Three New Arylnaphthalene Lignans from Schisandra propinqua var. sinensis. Li, X.N., C. Lei, L.M. Yang, H.M. Li, S.X. Huang, X. Du, J.X. Pu, W.L. Xiao, Y.T. Zheng, and H.D. Sun, Fitoterapia, 2012. 83(1): p. 249-252; PMID[WOS:000300201300037].
[WOS]. HIV_0302-031512.

29. Involvement of K(v)1.3 and p38 MAPK Signaling in HIV-1 Glycoprotein 120-induced Microglia Neurotoxicity. Liu, J., C. Xu, L. Chen, P. Xu, and H. Xiong, Cell Death & Disease, 2012. 3; PMID[WOS:000300322700008].
[WOS]. HIV_0302-031512.

30. Quinoxalinone Inhibitors of the Lectin DC-SIGN. Mangold, S.L., L. Prost, and L. Kiessling, Chemical Science, 2012. 3(3): p. 772-777; PMID[WOS:000299949500016].
[WOS]. HIV_0302-031512.

31. HIV-1 Subtype and Virological Response to Antiretroviral Therapy: Acquired Drug Resistance. Soares, E.A., A.F. Santos, and M.A. Soares, Clinical Infectious Diseases, 2012. 54(5): p. 738-738; PMID[WOS:000300228300025].
[WOS]. HIV_0302-031512.

32. Dihydro-alkoxyl-benzyl-oxopyrimidine Derivatives (DABOs) As Non-nucleoside Reverse Transcriptase Inhibitors: An Update Review (2001-2011). Yang, S.Q., F.E. Chen, and E. De Clercq, Current Medicinal Chemistry, 2012. 19(2): p. 152-162; PMID[WOS:000300284100001].
[WOS]. HIV_0302-031512.

Patent citations

33. Piperidine-4-Carboxamide Derivatives as Ccr5 Antagonists and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of HIV Infection and Autoimmune Diseases. Liu, T., X. Xie, Y. Hu, Z. Weng, and W. Wei. Patent. 2012. 2010-10275734 102311380: 17pp.

[Patent]. HIV_0217-030112.

34. 7,9-Nitrogen radical-4-oxo-4h-Pyrido[1,2-B]pyrimidine-2-carboxylic acid Benzyl amides as Antiviral Agents and Their Preparation. Rhodes, D.I., J.J. Deadman, G.T. Le, N.A. Van De Graff, L. Lu, X. Li, X. Feng, and C. Yu. Patent. 2012. 2011-AU894 2012006680: 118pp.

[Patent]. HIV_0217-030112.

35. Indolyl- and Azaindolyloxoacetylpiperazines and Related Compounds and Their Preparation and Use for the Treatment of HIV Infection.. Wang, T., Z. Zhang, Z. Yin, J.F. Kadow, and N.A. Meanwell. Patent. 2012. 2011-US46589 2012019003: 221pp.

[Patent]. HIV_0217-030112.